Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster

The novel coronavirus (SARS-CoV-2) epidemic continues to be a global public crisis affecting human health. Many research groups are developing different types of vaccines to suppress the spread of SARS-CoV-2, and some vaccines have entered phase III clinical trials and have been rapidly implemented....

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Zhenye, Li, Xueqi, Gao, Yang, Wang, Lichun, Fan, Shengtao, Xu, Xingli, Jiang, Guorun, Cui, Pingfang, Li, Dandan, Liao, Yun, Yu, Li, Zhao, Heng, Zhang, Ying, Li, Qihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781188/
https://www.ncbi.nlm.nih.gov/pubmed/36560406
http://dx.doi.org/10.3390/vaccines10121996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781188/
https://www.ncbi.nlm.nih.gov/pubmed/36560406
http://dx.doi.org/10.3390/vaccines10121996

Ejemplares similares